Ten simple rules to power drug discovery with data science

Enrico Ferrero; Sophie Brachat; Jeremy L. Jenkins; Philippe Marc; Peter Skewes-Cox; Robert C. Altshuler; Caroline Gubser Keller; Audrey Kauffmann; Erik K. Sassaman; Jason M. Laramie; Birgit Schoeberl; Mark L. Borowsky; Nikolaus Stiefl

doi:10.1371/journal.pcbi.1008126

Loading metrics

Open Access

Ten simple rules to power drug discovery with data science

Enrico Ferrero ,

* E-mail: enrico.ferrero@novartis.com

Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Basel, Switzerland

http://orcid.org/0000-0002-8362-100X

⨯
Sophie Brachat,

Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Basel, Switzerland

http://orcid.org/0000-0002-3398-8225

⨯
Jeremy L. Jenkins,

Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

http://orcid.org/0000-0001-9795-0771

⨯
Philippe Marc,

Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Basel, Switzerland

http://orcid.org/0000-0002-0064-0572

⨯
Peter Skewes-Cox,

Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Emeryville, California, United States of America

http://orcid.org/0000-0003-1633-5190

⨯
Robert C. Altshuler,

Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

http://orcid.org/0000-0001-5096-1932

⨯
Caroline Gubser Keller,

Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Basel, Switzerland

http://orcid.org/0000-0001-9459-6076

⨯
Audrey Kauffmann,

Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Basel, Switzerland
⨯
Erik K. Sassaman,

Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

http://orcid.org/0000-0001-5521-7635

⨯
Jason M. Laramie,

Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America
⨯
Birgit Schoeberl,

Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

http://orcid.org/0000-0002-1990-5315

⨯
Mark L. Borowsky,

Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America
⨯
Nikolaus Stiefl

Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Basel, Switzerland

http://orcid.org/0000-0003-2562-7080

⨯

Ten simple rules to power drug discovery with data science

Enrico Ferrero,
Sophie Brachat,
Jeremy L. Jenkins,
Philippe Marc,
Peter Skewes-Cox,
Robert C. Altshuler,
Caroline Gubser Keller,
Audrey Kauffmann,
Erik K. Sassaman,
Jason M. Laramie

Published: August 27, 2020
https://doi.org/10.1371/journal.pcbi.1008126

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Scientists
Is the Subject Area "Scientists" applicable to this article?

Thanks for your feedback.
Drug discovery
Is the Subject Area "Drug discovery" applicable to this article?

Thanks for your feedback.
Data visualization
Is the Subject Area "Data visualization" applicable to this article?

Thanks for your feedback.
Data management
Is the Subject Area "Data management" applicable to this article?

Thanks for your feedback.
Data mining
Is the Subject Area "Data mining" applicable to this article?

Thanks for your feedback.
Machine learning
Is the Subject Area "Machine learning" applicable to this article?

Thanks for your feedback.
Metadata
Is the Subject Area "Metadata" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.